IT & Data Management

Global pharmaceutical companies have faced significant scrutiny for various issues, such as inconsistent drug availability, a lack of transparency in environmental, social, and governance practices, and a surge in counterfeit medications. This increased scrutiny indicates that the traditional manufacturing...

In late 2020, Pfizer, a drug manufacturer, faced challenges in meeting its Covid-19 vaccine production targets due to quality issues with raw materials, causing disruptions in the global supply chain. The situation worsened in March 2021 when contamination issues...

A discussion paper has been published by the US FDA that aims at complementing and informing future guidance on artificial intelligence (AI) and machine learning (ML) usage in drug development. The purpose of this paper is to initiate an...

Adherence specialists AARDEX Group are proud to announce its partnership with other industry leaders on DiMe’s new Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework project. Organizations are taking digital clinical measures and products to scale, meaning digital...

The pharmaceutical sector happens to be significant for enhancing and sustaining public health. It is responsible when it comes to exploring, developing, producing, as well as marketing drugs and other pharmaceutical products. That said, it faces loads of challenges...

One of the market reports has gone on to show that the digital biomanufacturing segment is expected to grow at a CAGR of 11% between 2023 and 2035 and will be driven largely by digital transformation. The influencing factors identified...

Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, announced the expansion of its trusted participant-centered offerings with a robust series of solution enhancements. To enable sponsors, CROs and sites to deliver a consistent...